EP3209295
METHODS OF TREATING OCULAR CONDITIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
19.10.2015:
9.12.2020:
15852340.7
:
18.10.2035
:
METHODS OF TREATING OCULAR CONDITIONS
19.10.2015
9.12.2020
:
Oyster Point Pharma, Inc.:
202 Carnegie Center, Suite 109, Princeton, New Jersey 08540, US
:
ACKERMANN, Douglas Michael, Jr.:
San Francisco, California 94131, US
:
LOUDIN, James:
Houston, Texas 77024, US
:
MANDELL, Kenneth J.:
Arlington, Massachusetts 02474, US
:
201462066280 P:
20.10.2014:
US
:
201562100844 P:
7.1.2015:
US
:
US2015056273:
19.10.2015
:
A61K 31/55, A61K 31/436, A61K 38/13, A61K 31/439, A61K 31/4427, A61K 31/4985, A61K 31/4439, A61K 31/4995, A61K 45/06, A61P 27/02, A61P 11/02, A61P 25/02, A61K 9/00, A61K 9/08